Delivered a technically rigorous and investment-grade valuation for a US private equity anchor investor assessing a major healthcare asset. The report included comprehensive financial analysis, scenario-based valuation models, and strategic insights to guide high-stakes investment decisions.
Valuation – Large-Cap Healthcare Company (USA)
